Association Between GLP1R Agonists and Prostate, Kidney, and Bladder Cancers

被引：1
|
作者：
Bukavina, Laura [1 ,2 ]
Helstrom, Emma [3 ]
Wallis, Christopher J. D. [4 ,5 ,6 ]
Fulmes, Antoniy [1 ]
Calaway, Adam [1 ]
Correa, Andres [3 ]
Rhodes, Stephen [1 ]
机构：
[1] Univ Hosp Cleveland, Med Ctr, Cleveland, OH USA
[2] Case Western Reserve Sch Med, Cleveland, OH USA
[3] Fox Chase Canc Ctr, Philadelphia, PA USA
[4] Univ Toronto, Dept Surg, Div Urol, Toronto, ON, Canada
[5] Mt Sinai Hosp, Dept Surg, Div Urol, Toronto, ON, Canada
[6] Univ Hlth Network, Dept Surg Oncol, Toronto, ON, Canada
来源：
EUROPEAN UROLOGY ONCOLOGY | 2024年 / 7卷 / 06期
关键词：
RISK;
D O I：
10.1016/j.euo.2024.04.006
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1543 / 1544
页数：2
相关论文
共 50 条
  • [41] Genetic Evidence for Repurposing of GLP1R (Glucagon-Like Peptide-1 Receptor) Agonists to Prevent Heart Failure
    Daghlas, Iyas
    Karhunen, Ville
    Ray, Devleena
    Zuber, Verena
    Burgess, Stephen
    Tsao, Philip S.
    Lynch, Julie A.
    Lee, Kyung Min
    Voight, Benjamin F.
    Chang, Kyong-Mi
    Baker, Emma H.
    Damrauer, Scott M.
    Howson, Joanna M. M.
    Vujkovic, Marijana
    Gill, Dipender
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2021, 10 (13):
  • [42] Contribution of SNV GLP1R in Diseasome of Metabolically Unhealthy Obesity
    Abaturov, Aleksandr
    Nikulina, Anna
    Nikulin, Dmytro
    Holikova, Anastasiia
    Dikhtyarenko, Daryna
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2024, 153
  • [43] Brexpiprazole caused glycolipid metabolic disorder by inhibiting GLP1/GLP1R signaling in rats
    Li, De-juan
    Yue, Qin
    Liu, Lu
    Che, Ke-ke
    Liu, Xue-mei
    Hu, Chang-hua
    ACTA PHARMACOLOGICA SINICA, 2021, 42 (08) : 1267 - 1279
  • [44] Commentary on association of clinical prostate and bladder cancers
    Nieder, Alan M.
    JOURNAL OF UROLOGY, 2008, 179 (05): : S6 - S6
  • [45] GLP-1R AGONISTS AND WEIGHT LOSS GLP-1R agonists are not a quick fix for weight loss
    Iverson, Kristen A.
    BMJ-BRITISH MEDICAL JOURNAL, 2012, 344
  • [46] Brexpiprazole caused glycolipid metabolic disorder by inhibiting GLP1/GLP1R signaling in rats
    De-juan Li
    Qin Yue
    Lu Liu
    Ke-ke Che
    Xue-mei Liu
    Chang-hua Hu
    Acta Pharmacologica Sinica, 2021, 42 : 1267 - 1279
  • [47] GLP-1 Receptor Agonists and Kidney Protection
    Greco, Eulalia Valentina
    Russo, Giuseppina
    Giandalia, Annalisa
    Viazzi, Francesca
    Pontremoli, Roberto
    De Cosmo, Salvatore
    MEDICINA-LITHUANIA, 2019, 55 (06):
  • [48] Synchronous Primary Cancers of Urinary Bladder and Kidney and Prostate
    Tiwari, Punit
    Tripathi, Astha
    Bansal, Punit
    Vijay, Mukesh
    Gupta, Aman
    Kundu, Anup Kumar
    SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION, 2012, 23 (04) : 786 - 789
  • [49] Incidence of kidney, bladder, and prostate cancers in Korea: An update
    Song, Wan
    Jeon, Hwang Gyun
    KOREAN JOURNAL OF UROLOGY, 2015, 56 (06) : 422 - 428
  • [50] The Search for the Ideal Weight GLP1R Neurons for Satiety Without Aversion
    Hung, Lin y.
    Margolis, Kara gross
    GASTROENTEROLOGY, 2024, 167 (07) : 1493 - 1493
12345